Your World, Fully Explored.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Leo XIV
Pope Francis
Mother's Day
Vatican
Artificial Intelligence
Catholic Church
Parade
Social Media
World War II
European Union
Stock Markets
Vladimir Putin
Published • loading... • Updated

Senti Bio’s SENTI-202, a First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT ...

Summary by Enid News & Eagle
Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2025

4 Articles

All
Left
1
Center
1
Right
Hastings TribuneHastings Tribune
Reposted by
Enid News & EagleEnid News & Eagle
Center

Senti Bio’s SENTI-202, a First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT ...

Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2025

Read Full Article
GeneOnline NewsGeneOnline News

Senti Biosciences to Showcase New Cell & GeneTherapy Data at AACR Annual Meeting 2025

Senti Biosciences will present clinical and preclinical data on Gene Circuit-enabled therapies at AACR Annual Meeting 2025.

Read Full Article
Pharmacy TimesPharmacy Times

AACR 2025: Off-the-Shelf CAR NK Therapy SENTI-202 Shows Potential for Complete Remission in R/R AML

Interim results from the phase 1 SENTI-202-101 trial show that SENTI-202, a logic-gated, off-the-shelf chimeric antigen receptor natural killer (CAR NK) cell therapy, achieved complete remission in 4 patients with relapsed or refractory (R/R) acute myeloid leukemia (AML).

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Pharmacy Times broke the news in on Sunday, April 27, 2025.
Sources are mostly out of (0)

Similar News Topics

News
For You
SearchBlindspotLocal